Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caleb Banta-Green

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|August 19, 2014
The dueling obligations of opioid stewardshipPhillip Coffin, Caleb Banta-Green
Annals of Internal Medicine|December 11, 2013
The dueling obligations of opioid stewardshipPhillip Coffin, Caleb Banta-Green
Addiction (Abingdon, England)|November 7, 2017
The need for better marijuana sales dataJason Williams, Caleb Banta-Green, Daniel Burgard
Environmental Science & Technology|February 6, 2009
Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in U.S. wastewatersAurea C Chiaia, Caleb Banta-Green, Jennifer Field
Environmental Science & Technology|December 19, 2013
Working upstream: how far can you go with sewage-based drug epidemiology?Daniel A Burgard, Caleb Banta-Green, Jennifer A Field
Journal of Substance Abuse Treatment|September 4, 2012
Who prescribes buprenorphine for rural patients? The impact of specialty, location and practice type in Washington StateErik Kvamme, Mary Catlin, Caleb Banta-Green, et al.
Pediatrics|June 11, 2025
Adolescent and Young Adult Access to Opioid Use Disorder CareAlexis Ball, Teresa Winstead, Samyukta Singh, et al.
Pain|March 26, 2010
Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer painMark D Sullivan, Michael Von Korff, Caleb Banta-Green, et al.
Substance Use & Misuse|July 29, 2005
Epidemiology of MDMA and associated club drugs in the Seattle areaCaleb Banta-Green, Gary Goldbaum, Susan Kingston, et al.
Addiction (Abingdon, England)|July 15, 2016
Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'Maya Doe-Simkins, Caleb Banta-Green, Corey S Davis, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|August 19, 2014
The dueling obligations of opioid stewardshipPhillip Coffin, Caleb Banta-Green
Annals of Internal Medicine|December 11, 2013
The dueling obligations of opioid stewardshipPhillip Coffin, Caleb Banta-Green
Addiction (Abingdon, England)|November 7, 2017
The need for better marijuana sales dataJason Williams, Caleb Banta-Green, Daniel Burgard
Environmental Science & Technology|February 6, 2009
Eliminating solid phase extraction with large-volume injection LC/MS/MS: analysis of illicit and legal drugs and human urine indicators in U.S. wastewatersAurea C Chiaia, Caleb Banta-Green, Jennifer Field
Environmental Science & Technology|December 19, 2013
Working upstream: how far can you go with sewage-based drug epidemiology?Daniel A Burgard, Caleb Banta-Green, Jennifer A Field
Journal of Substance Abuse Treatment|September 4, 2012
Who prescribes buprenorphine for rural patients? The impact of specialty, location and practice type in Washington StateErik Kvamme, Mary Catlin, Caleb Banta-Green, et al.
Pediatrics|June 11, 2025
Adolescent and Young Adult Access to Opioid Use Disorder CareAlexis Ball, Teresa Winstead, Samyukta Singh, et al.
Pain|March 26, 2010
Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer painMark D Sullivan, Michael Von Korff, Caleb Banta-Green, et al.
Substance Use & Misuse|July 29, 2005
Epidemiology of MDMA and associated club drugs in the Seattle areaCaleb Banta-Green, Gary Goldbaum, Susan Kingston, et al.
Addiction (Abingdon, England)|July 15, 2016
Comments on Strang et al. (2016): 'Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?'Maya Doe-Simkins, Caleb Banta-Green, Corey S Davis, et al.
Pageof 2